Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.

Dominic Kelly, Gillian Cockerill, Leong L Ng, Matt Thompson, Sohail Khan, Nilesh J Samani, Iain B Squire
Author Information
  1. Dominic Kelly: Department of Vascular Surgery, St George's Hospital Medical School, London, UK.

Abstract

AIM: To describe temporal profiles of plasma matrix metalloproteinases (MMP-2 and MMP-9), and their relationship with echocardiographic (Echo) parameters of left ventricular (LV) function and remodelling, after acute myocardial infarction (AMI) in man.
METHODS AND RESULTS: Plasma MMP-2 and MMP-9 were assayed at intervals (0-12, 12-24, 24-48, 48-72, 72-96, and > 96 h) in 91 patients with AMI (ST-elevation/non-ST-elevation 77/24; 73% male; 40% anterior site) and on a single occasion in 172 age- and sex-matched control subjects with stable coronary artery disease. Echo assessment of LV volumes, LV ejection fraction (LVEF), and wall motion index score were assessed before discharge and at follow-up (median 176, range 138-262 days) for patients and on a single occassion in controls. Plasma MMP-2 was similar at all times after AMI, elevated when compared with control (P = 0.005-0.001) and unrelated to LV function or volume during index admission or at follow-up. Maximal MMP-9 was seen at 0-12 h and was elevated when compared with control (P = 0.002) followed by fall to a plateau. Both maximal and plateau MMP-9 concentration correlated with white blood cell (WBC, P = 0.023 to < 0.001) and neutrophil count (P = 0.014 to < 0.001). Maximal MMP-9 had independent predictive value for lower LVEF (P = 0.004) during admission and for greater change in LV end-diastolic volume between admission and follow-up (R = 0.3, P = 0.016). In contrast, higher plateau levels of MMP-9 were associated with relative preservation of LV function (increasing LVEF, P = 0.002; decreasing WMIS, P = 0.009) and less change in end-systolic volume and end-diastolic volumes after discharge (P = 0.001 and 0.024, respectively).
CONCLUSION: Both MMP-9 and MMP-2 are elevated following AMI. The biphasic profile of plasma MMP-9 is related to LV remodelling and function following AMI in man. Higher early levels of MMP-9 associate with the extent of LV remodelling and circulating WBC levels. In contrast, higher plateau levels later after AMI are associated with relative preservation of LV function. Temporal profile, rather than absolute magnitude, of MMP-9 activity appears to be important for LV remodelling after AMI.

References

  1. Circulation. 1998 Oct 27;98(17):1728-34 [PMID: 9788826]
  2. Circulation. 1999 Jun 15;99(23):3063-70 [PMID: 10368126]
  3. Circ Res. 1999 Aug 20;85(4):364-76 [PMID: 10455065]
  4. Nat Med. 1999 Oct;5(10):1135-42 [PMID: 10502816]
  5. Circulation. 2004 Nov 23;110(21):3306-12 [PMID: 15545516]
  6. Circulation. 2005 Apr 12;111(14):1800-5 [PMID: 15809374]
  7. Toxicology. 2005 Jul 1;211(1-2):36-48 [PMID: 15863246]
  8. Am J Cardiol. 2005 Jul 1;96(1):31-4 [PMID: 15979428]
  9. Int J Cardiol. 2005 Nov 2;105(2):203-8 [PMID: 16243114]
  10. Circulation. 2006 Sep 5;114(10):1020-7 [PMID: 16923753]
  11. J Am Coll Cardiol. 2006 Jul 4;48(1):15-20 [PMID: 16814643]
  12. J Card Fail. 2006 Feb;12(1):66-72 [PMID: 16500583]
  13. Circulation. 2006 Feb 14;113(6):834-41 [PMID: 16461815]
  14. Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):250-6 [PMID: 16339501]
  15. Circulation. 2003 Apr 1;107(12):1579-85 [PMID: 12668489]
  16. J Thorac Cardiovasc Surg. 2003 Mar;125(3):602-10 [PMID: 12658202]
  17. Circulation. 2003 Feb 4;107(4):618-25 [PMID: 12566376]
  18. Circulation. 2002 Dec 3;106(23):2913-8 [PMID: 12460871]
  19. Biochem Soc Trans. 2002 Apr;30(2):98-102 [PMID: 12023833]
  20. Circulation. 2002 Feb 12;105(6):753-8 [PMID: 11839633]
  21. Cardiovasc Res. 2002 Jan;53(1):31-47 [PMID: 11744011]
  22. Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H987-94 [PMID: 11514263]
  23. Circulation. 2001 May 1;103(17):2181-7 [PMID: 11331260]
  24. Life Sci. 2001 Jan 5;68(7):799-814 [PMID: 11205871]
  25. Eur Heart J. 2000 Sep;21(18):1514-21 [PMID: 10973765]
  26. J Clin Invest. 2000 Jul;106(1):55-62 [PMID: 10880048]
  27. Cardiovasc Res. 2000 May;46(2):307-15 [PMID: 10773235]
  28. Science. 1997 Sep 26;277(5334):2002-4 [PMID: 9302297]
  29. Int Rev Cytol. 1996;169:151-81 [PMID: 8843654]
  30. Circulation. 1990 Apr;81(4):1161-72 [PMID: 2138525]
  31. Circulation. 1987 Jul;76(1):44-51 [PMID: 3594774]
  32. N Engl J Med. 1983 Aug 11;309(6):331-6 [PMID: 6866068]
  33. J Card Fail. 2004 Aug;10(4):328-33 [PMID: 15309700]
  34. Circulation. 2004 Jun 15;109(23):2850-6 [PMID: 15173025]
  35. Life Sci. 2004 Feb 6;74(12):1561-72 [PMID: 14729404]
  36. Circulation. 2003 Oct 7;108(14):1753-9 [PMID: 12975256]
  37. Eur J Heart Fail. 2003 Aug;5(4):499-506 [PMID: 12921811]
  38. Circulation. 1998 May 5;97(17):1708-15 [PMID: 9591765]
  39. Circulation. 1998 May 19;97(19):1921-9 [PMID: 9609085]
  40. J Am Coll Cardiol. 1998 Aug;32(2):368-72 [PMID: 9708462]

Grants

  1. PG/03/155/16412/British Heart Foundation

MeSH Term

Adult
Aged
Aged, 80 and over
Case-Control Studies
Cohort Studies
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Middle Aged
Myocardial Infarction
Prospective Studies
Ventricular Dysfunction, Left
Ventricular Remodeling

Chemicals

Matrix Metalloproteinase 2
Matrix Metalloproteinase 9

Word Cloud

Created with Highcharts 10.0.00MMP-9LV=PAMIfunctionremodellingMMP-2001plateaulevelsPlasmacontrolLVEFfollow-upelevatedvolumeadmissionplasmamatrixEcholeftventricularacutemyocardialinfarctionman0-12hpatientssinglevolumesindexdischargecomparedMaximal002WBC<changeend-diastoliccontrasthigherassociatedrelativepreservationfollowingprofileAIM:describetemporalprofilesmetalloproteinasesrelationshipechocardiographicparametersMETHODSANDRESULTS:assayedintervals12-2424-4848-7272-96>9691ST-elevation/non-ST-elevation77/2473%male40%anteriorsiteoccasion172age-sex-matchedsubjectsstablecoronaryarterydiseaseassessmentejectionfractionwallmotionscoreassessedmedian176range138-262daysoccassioncontrolssimilartimes005-0unrelatedseenfollowedfallmaximalconcentrationcorrelatedwhitebloodcell023neutrophilcount014independentpredictivevaluelower004greaterR3016increasingdecreasingWMIS009lessend-systolic024respectivelyCONCLUSION:biphasicrelatedHigherearlyassociateextentcirculatinglaterTemporalratherabsolutemagnitudeactivityappearsimportantmetalloproteinase-9man:prospectivecohortstudy

Similar Articles

Cited By